ICU Medical Inc (ICUI)

151.30
2.80 1.89
NASDAQ : Health Care
Prev Close 148.50
Open 150.25
Day Low/High 150.20 / 151.80
52 Wk Low/High 85.56 / 124.69
Volume 126.16K
Avg Volume 126.90K
Exchange NASDAQ
Shares Outstanding 19.80M
Market Cap 2.94B
EPS 3.90
P/E Ratio 40.59
Div & Yield N.A. (N.A)

Latest News

ICU Medical Completes The Acquisition Of Hospira Infusion Systems From Pfizer

ICU Medical Completes The Acquisition Of Hospira Infusion Systems From Pfizer

The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio creates a leading pure-play infusion therapy company with focus and global scale

Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees

Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees

Here are the winning banks.

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

ICU Medical will pay $900 million for the infusion therapy unit rather than $1 billion.

These 5 Health Care Stocks Are Breaking Out This Christmas

These 5 Health Care Stocks Are Breaking Out This Christmas

The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.

ICU Medical Launches The All-New Diana™ Compounding Workflow System At The American Society Of Health-System Pharmacists (ASHP) Midyear Meeting In Las Vegas

ICU Medical Launches The All-New Diana™ Compounding Workflow System At The American Society Of Health-System Pharmacists (ASHP) Midyear Meeting In Las Vegas

Diana is the first and only system to combine automated compounding and IV workflow technologies with remote pharmacist notification to help minimize errors and maximize drug compounding efficiency and safety

Short Interest Increases 55.7% For ICUI

Short Interest Increases 55.7% For ICUI

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 296,246 share increase in total short interest for ICU Medical, Inc. , to 828,440, an increase of 55.67% since 10/14/2016.

ICUI Crosses Above Average Analyst Target

ICUI Crosses Above Average Analyst Target

In recent trading, shares of ICU Medical, Inc. have crossed above the average analyst 12-month target price of $142.50, changing hands for $142.80/share.

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

ICU Medical (ICUI) purchased Pfizer's (PFE) infusion therapy business for $1 billion,

Stocks Hold Mixed as Crude Settles Above $50, Wall Street Eyes Jobs Report

Stocks Hold Mixed as Crude Settles Above $50, Wall Street Eyes Jobs Report

Stocks hold mixed on Thursday afternoon as crude oil enjoys another rally and Wall Street looks toward the Friday release of the monthly jobs report.

ICU Medical Deal No Game Changer for Pfizer

The deal will close in the first quarter.

ICU Medical Inc. To Acquire The Hospira Infusion Systems Business from Pfizer Inc. For $1 Billion In Cash And Stock

ICU Medical Inc. To Acquire The Hospira Infusion Systems Business from Pfizer Inc. For $1 Billion In Cash And Stock

The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio will create a leading pure-play infusion therapy company

Strong And Under The Radar: ICU Medical (ICUI)

Strong And Under The Radar: ICU Medical (ICUI)

Trade-Ideas LLC identified ICU Medical (ICUI) as a strong and under the radar candidate

Noteworthy Friday Option Activity: ICUI, CONN, ITCI

Noteworthy Friday Option Activity: ICUI, CONN, ITCI

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ICU Medical, Inc. , where a total of 1,022 contracts have traded so far, representing approximately 102,200 underlying shares.

ICU Medical, Inc. Announces Fourth Quarter And Fiscal Year 2015 Results

ICU Medical, Inc. Announces Fourth Quarter And Fiscal Year 2015 Results

Fiscal Year 2015 Adjusted EBITDA Increased 54% to $114 Million